Ovarian Clear Cell Tumor — Trials

Ovarian Clear Cell Tumor — Trials · CancerIndex

Clinical trials

Registered studies

69 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06393751	Testing the Addition of ASTX660 (Tolinapant) to the Usual Chemotherapy Treatment (Paclitaxel With or Without Bevacizumab) in Patients With Recurrent Ovarian Cancer	withdrawn	Phase 1 / Phase 2	0	National Cancer Institute (NCI)NIH	0	Jun 3, 2025	clinicaltrials
NCT04611139	Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers	withdrawn	Phase 1	0	HonorHealth Research InstituteOTHER	1	Mar 2, 2022	clinicaltrials
NCT02470559	Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent	withdrawn	Phase 1	0	Barbara Ann Karmanos Cancer InstituteOTHER	0	Feb 17, 2016	clinicaltrials

Data updated 22 days agoSource updated Jun 3, 2025source: clinicaltrials